Controversies in endometrial cancer
Read Online
Share

Controversies in endometrial cancer

  • 32 Want to read
  • ·
  • 41 Currently reading

Published by Baillière Tindall in London .
Written in English


Book details:

Edition Notes

StatementM.A. Quinn, guest editor.
SeriesBaillière"s best practice & research -- 15, 3
ContributionsQuinn, M. A.
The Physical Object
Paginationp.p.341-489 ;
Number of Pages489
ID Numbers
Open LibraryOL19192504M

Download Controversies in endometrial cancer

PDF EPUB FB2 MOBI RTF

Controversies in the management of endometrial cancer: a survey of the Korean Gynecologic Oncology Group Jung-Yun Lee, 1 Kidong Kim, 2 Taek Sang Lee, 3 Sokbom Kang, 4 Seok Ju Seong, 5 Jae Weon Kim, 6 and Byoung-Gie Kim 7Cited by: 8. Endometrial cancer (EC) is the most frequent cancer of the female genital tract, especially in developed countries and the seventh most common cause of death from cancer in women in Western : Fuat Demirkiran. Endometrial cancer is the most common cancer of the female genital tract; with 20%% diagnosed pre-menopausally, the median age in this group of patients is 40 yrs (range yrs) (1). This syndrome occurs in nearly 10% of endometrial cancer patients less than 50 years. of age, compared to the 2% to 5% of all endometrial cancer cases, and the risk of ovarian. cancer in patients affected by HNPCC is 10% to 12%.

The controversies in the surgical management of endometrial cancer are discussed, as are the minimally invasive surgical techniques. The international group of authors and editors provide a worldwide perspective about areas of agreement, topics of controversies, and issues that need yet to Cited by: The value of adjuvant systemic chemotherapy in patients with high-risk early stage endometrial cancer is still controversial. The GOG 34 trial, using single-agent doxorubicin, did not show any benefit women with clinical stage I or II (occult) disease who had one or Cited by: 4. "Although there have been significant recent advances in our understanding of endometrial cancer biology, many aspects of treatment remain mired in controversy, including the role of surgical lymph. This is a novel text that highlights the controversial areas in the management of gynecological cancers. None of the topics in this book have definitive answers; they represent the everyday decision-making facing gynecologists, oncologists, radiologists, pathologists and other health professionals treating women with these conditions.

Endometrial cancer (EC) remains the most common malignancy of the female genital tract. The median age at diagnosis is the sixth decade, with abnormal uterine bleeding at the presentation in 90%. Controversies in the Management of Gynecological Cancers offers a unique assessment of the opposing sides of the controversial issues associated with gynecological cancers, and aims to provide professionals in the field with a keener sense of the underlying evidence-base. Controversies in the Management of Endometrial Carcinoma Article (PDF Available) in Obstetrics and Gynecology International () June with Reads How we measure 'reads'. Endometrial cancer (EC) remains the most common malignancy of the female genital tract. The median age at diagnosis is the sixth decade, with abnormal uterine bleeding at the presentation in 90% of the patients. Surgical treatment, including complete hysterectomy, removal of remaining adnexal structures, and an appropriate surgical staging, represents the milestone of curative therapy for Cited by: